Top headlines in AMD/Retina: AI and the retina; imaging devices for screening; and more
Click Here to Manage Email Alerts
In this edition, digital imaging and AI advance investigation of systemic disease through the retina; handheld retinal imaging devices may have utility in screening; Xipere launches in the US; and more.
Read the full coverage here:
Digital imaging, AI advance investigation of systemic disease through the retina
No additional visual benefit seen with nesvacumab-aflibercept combination in DME
Soft drusen, subretinal drusenoid deposits may be separate diseases leading to AMD
Handheld retinal imaging devices may have utility in screening
References:
Healio Interviews
Brown DM, et al. Retina. 2022;doi:10.1097/IAE.0000000000003441.
Thomson RJ, et al. Retina. 2022;doi:10.1097/IAE.0000000000003460.
Salongcay RP, et al. Ophthalmol Retina. 2022;doi:10.1016/j.oret.2022.03.002
Collapse
Click Here to Manage Email Alerts
